ESR1 and breast cancer: In 2023, Pusparini et al. (Pusparini et al. 2023) proposed a QSAR framework utilizing deep learning to predict estrogen receptor alpha inhibitors, establishing five classification models for predicting these inhibitors in breast cancer.